Healthcare >> CEO Interviews >> May 10, 2004
Paul McCormick is President and Chief Executive Officer of Endologix,
Inc. Mr. McCormick has over 20 years of experience in the medical
device industry. Prior to joining Endologix, Mr. McCormick was Director
of Sales for Progressive angioplasty Systems (PAS), a manufacturer of
coronary catheters. PAS was acquired by U.S. Surgical Corporation in
1997. Prior to PAS, Mr. McCormick was Regional Sales Director for Heart
Technology Inc. (HTI), the manufacturer of the Rotablator Catheter. HTI
was acquired by Boston Scientific Corporation in 1996. The remainder of
his career was spent in various sales and marketing positions at
Trimedyne, U.S. Surgical Corporation and Johnson & Johnson. Mr.
McCormick received a BA from Northwestern University. Profile
Mr. McCormick: Endologix has developed a minimally invasive technology
to treat abdominal aortic aneurysms, which are commonly referred to
